About Remidex Pharma
Remidex Pharma is a company based in Bengaluru (India) founded in 1981 by Dayanand S Rao was acquired by Jubilant Ingrevia in March 2026. It operates as a B2B. The company has 123 employees as of March 31, 2024. Remidex Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Bengaluru, India
- Employees 123 as on 31 Mar, 2024
- Founders Dayanand S Rao
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Remidex Pharma Private Limited
- Date of Incorporation 15 Jun, 1981
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$3.68 M (USD)0.34as on Mar 31, 2024
-
Net Profit
-$170.26 K (USD)41.79as on Mar 31, 2024
-
EBITDA
$309.85 K (USD)52.02as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
123
as on Mar 31, 2024
-
Acquired by
Jubilant Ingrevia
(Mar 14, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Remidex Pharma
Detailed funding history for Remidex Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Remidex Pharma
Remidex Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Jubilant Ingrevia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Key ingredients for health and nutrition solutions are manufactured.
|
Locked | Locked | Locked |
Investor details for Remidex Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Remidex Pharma
Investment portfolio details for Remidex Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Remidex Pharma
Detailed financials for Remidex Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remidex Pharma Comparisons
Peer comparison for Remidex Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Remidex Pharma
Remidex Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Remidex Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remidex Pharma
Complete news archive for Remidex Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Remidex Pharma
Remidex Pharma was founded in 1981.
Remidex Pharma is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Mar 31, 2024, the latest employee count at Remidex Pharma is 123.
Annual revenue of Remidex Pharma is $3.68M as on Mar 31, 2024.
Remidex Pharma manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and nutraceutical production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Remidex Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Remidex Pharma has 1 investor. Key investors include Jubilant Ingrevia.